Edwards Lifesciences predicts double-digit growth for 2025

Edwards Lifesciences is anticipating strong growth in revenue and earnings per share this year. They expect to see sales and profits increase by double digits. This comes as market conditions have changed in 2025. Last year, technology and consumer discretionary sectors were weaker. Now, health care and energy sectors, which struggled before, are showing improvement. Investors are noticing this shift. The Health Care Select Sector SPDR Fund has gained attention as these areas become more attractive. Overall, Edwards Lifesciences is optimistic about their future performance amid this market shift.